WDR78 Antibodies

Santa Cruz Biotechnology delivers a wide array of WDR78 monoclonal antibodies for research applications. WDR78 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WDR78, or WD repeat domain 78, plays a crucial role in cellular processes such as signal transduction and gene regulation. The involvement of WDR78 in the modulation of protein interactions makes it an important target for understanding various biological pathways and disease mechanisms. Research focusing on WDR78 continues to reveal its potential implications in cancer and other disorders. Scientists worldwide rely on WDR78 monoclonal antibodies to explore cellular mechanisms and pathways. Understanding WDR78 function and regulation opens new possibilities in therapeutic development. WDR78 research has become increasingly significant in molecular biology and disease studies. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of WDR78 and its role in human health and disease.